P Chaiprasithikul

Learn More
Healthy volunteers were randomized to receive either intradermal purified chick embryo cell rabies vaccine (PCEC) alone (0.1 ml at each of two sites on days 0, 3 and 7, and at one site on days 28 and 90) (n = 81), or intradermal PCEC with one dose of human rabies immunoglobulin (HRIG) intramuscularly at 20 IU kg-1 on day 0 (n = 52). Neutralizing antibody(More)
The breakthrough in production of highly efficacious human and animal rabies vaccines has led to successful rabies control in developed countries, but rabies is still a major health problem in many developing countries. In Thailand, the new cell culture vaccines-purified chick embryo cell (PCEC), purified Vero cell (PVRV), purified duck embryo (PDEV) and(More)
Children who have close contact with rabid dogs, with a history of neither being bitten nor scratched nor licked on broken skin or on mucous membranes were given purified chick embryo rabies vaccine as pre-exposure prophylaxis. Thirteen children received 0.5 ml of the vaccine, while 12 children received 1 ml of the vaccine intramuscularly on days 0, 7 and(More)
During August 1988 to January 1990, the immunogenicity and safety of purified chick embryo cell rabies vaccine (PCEC) given by the conventional and abbreviated regimens in 82 vaccinees moderately to severely exposed to laboratory proven rabid animals were studied. The 16 vaccinees received PCEC six doses as conventional schedule on days 0, 3, 7, 14, 28 and(More)
Thailand is an endemic area for rabies, with approximately 300 human deaths reported annually. More than half of the rabies patients are children under 14 years of age. This paper reports clinical data of paediatric rabies cases occurring from 1980 to 1986, and the protective efficacies of human diploid cell rabies vaccine (HDCV) and purified Vero cell(More)
Twenty-nine vaccinees, 18 males, 11 females, aged 2-61 years (median 12 years) received PCEC intradermally for post-exposure prophylaxis during February to May 1989. Twenty-one cases received 4 sites of 0.1 ml ID on days 0, 3, 7 and 1 site ID on days 28 and 90. Four cases received 4 sites ID on days 0, 3, 7 and 1 site on days 14 and 28. The other 4 cases(More)